Ghent University Academic Bibliography

Advanced

Risico op colistineresistentie neemt toe

Benedicte Callens UGent, Freddy Haesebrouck UGent, Jeroen Dewulf UGent, Filip Boyen UGent, Patrick Butaye UGent, B Catry, P Wattiau and Evelyne De Graef UGent (2016) VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT. 85(1). p.36-40
abstract
In a recent article from China, a transferable resistance mechanism has been described in Escherichia coli (E. coli), isolated from food-producing animals, meat and hospital patients (Liu et al., 2015). Recently, this resistance mechanism has also been found in Denmark, France, the United Kingdom and Belgium. Colistin is considered as one of the last resort treatments against multi-resistant bacteria in human medicine, especially for patients with cystic fibrosis. Alertness is needed and the new resistance mechanism has to be detected properly in animal and human related bacteria.
Please use this url to cite or link to this publication:
author
organization
alternative title
Risk of colistin resistance on the rise
year
type
journalArticle (original)
publication status
published
subject
keyword
STAPHYLOCOCCUS-AUREUS, ESCHERICHIA-COLI, ZINC, PIGS, INCREASES
journal title
VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT
Vlaams Diergeneesk. Tijdschr.
volume
85
issue
1
pages
36 - 40
Web of Science type
Article
Web of Science id
000374209200006
JCR category
VETERINARY SCIENCES
JCR impact factor
0.288 (2016)
JCR rank
113/136 (2016)
JCR quartile
4 (2016)
ISSN
0303-9021
language
Dutch
UGent publication?
yes
classification
A1
copyright statement
I have retained and own the full copyright for this publication
id
7215557
handle
http://hdl.handle.net/1854/LU-7215557
date created
2016-05-18 15:52:15
date last changed
2017-02-10 13:17:54
@article{7215557,
  abstract     = {In a recent article from China, a transferable resistance mechanism has been described in Escherichia coli (E. coli), isolated from food-producing animals, meat and hospital patients (Liu et al., 2015). Recently, this resistance mechanism has also been found in Denmark, France, the United Kingdom and Belgium. Colistin is considered as one of the last resort treatments against multi-resistant bacteria in human medicine, especially for patients with cystic fibrosis. Alertness is needed and the new resistance mechanism has to be detected properly in animal and human related bacteria.},
  author       = {Callens, Benedicte and Haesebrouck, Freddy and Dewulf, Jeroen and Boyen, Filip and Butaye, Patrick and Catry, B and Wattiau, P and De Graef, Evelyne},
  issn         = {0303-9021},
  journal      = {VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT},
  keyword      = {STAPHYLOCOCCUS-AUREUS,ESCHERICHIA-COLI,ZINC,PIGS,INCREASES},
  language     = {dut},
  number       = {1},
  pages        = {36--40},
  title        = {Risico op colistineresistentie neemt toe},
  volume       = {85},
  year         = {2016},
}

Chicago
Callens, Benedicte, Freddy Haesebrouck, Jeroen Dewulf, Filip Boyen, Patrick Butaye, B Catry, P Wattiau, and Evelyne De Graef. 2016. “Risico Op Colistineresistentie Neemt Toe.” Vlaams Diergeneeskundig Tijdschrift 85 (1): 36–40.
APA
Callens, Benedicte, Haesebrouck, F., Dewulf, J., Boyen, F., Butaye, P., Catry, B., Wattiau, P., et al. (2016). Risico op colistineresistentie neemt toe. VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT, 85(1), 36–40.
Vancouver
1.
Callens B, Haesebrouck F, Dewulf J, Boyen F, Butaye P, Catry B, et al. Risico op colistineresistentie neemt toe. VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT. 2016;85(1):36–40.
MLA
Callens, Benedicte, Freddy Haesebrouck, Jeroen Dewulf, et al. “Risico Op Colistineresistentie Neemt Toe.” VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT 85.1 (2016): 36–40. Print.